doi:10.1098/rsos.210382
Psychoneuroendocrinology 38 : 19851993
Mitigating Side Effects People who are highly wary of taking any medication, but who desperately want to make a change to their health status, might be drawn to microdosing tirzepatide

Key timing considerations: Morning injection produces peak appetite suppression around mid-afternoon to evening, ideal for those who struggle with afternoon snacking and dinner portions Evening injection produces peak levels overnight and through the morning, beneficial for those who overeat at breakfast or need better fasting glucose control The 13-hour half-life means effects noticeably diminish in the latter half of each 24-hour cycle Consistency is absolutely critical with daily dosing because missed doses create more significant gaps in drug levels Many liraglutide users tie their injection to a specific daily habit (brushing teeth, morning coffee ritual) to prevent missed doses Dulaglutide (weekly injectable) Dosing frequency: Once weekly, same day each week Half-life: approximately 5 days (120 hours) Peak concentration: 24 to 72 hours after injection Recommended timing approach: Similar pharmacokinetic profile to tirzepatide in terms of half-life, though the mechanism is pure GLP-1 agonism

GLP1 agonist drugs, commonly known by brand names such as Ozempic and Mounjaro, reduce asthma symptoms in obese people according to a new study from the University of Aberdeen and The Observational and Pragmatic Research Institute (OPRI), Singapore
GHK-Cu products sold in the UK as cosmetics are not required to demonstrate clinical efficacy before being placed on the market